| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109223 neuroprotective effect; potent selective agonists of the EP4 subtype of prostaglandin E2 receptors |
| 09/19/2006 | US7109153 Photo-labile pro-fragrance conjugates |
| 09/14/2006 | WO2006096624A1 Process for the purification of substituted benzoxazole compounds |
| 09/14/2006 | WO2006096591A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | WO2006096584A1 Process for the preparation of substituted benzoxazole compounds |
| 09/14/2006 | WO2006094923A1 Sensor element and sensor containing said element |
| 09/14/2006 | WO2006094770A2 Apparatus and method for the final processing of a forming tool for a sheet-metal body part |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006094602A1 Indane |
| 09/14/2006 | WO2006034296A3 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 09/14/2006 | US20060205968 Process for producing optically active beta-amino acid derivatives |
| 09/14/2006 | US20060205952 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 09/14/2006 | US20060205799 Anti-cancer and anti-microbial oxazolidinones |
| 09/14/2006 | US20060205798 Crystal forms of 2-(3-Fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazole-5-ol |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205723 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/14/2006 | CA2601975A1 Process for the purification of substituted benzoxazole compounds |
| 09/14/2006 | CA2601973A1 Process for the preparation of substituted benzoxazole compounds |
| 09/14/2006 | CA2600606A1 Indanes |
| 09/14/2006 | CA2600339A1 Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/13/2006 | EP1700844A1 Phthalic acid diamide derivatives, agricultural and horticultural insecticides and a method for application of the insecticides |
| 09/13/2006 | EP1699784A1 Novel oxazolidinone derivatives |
| 09/13/2006 | EP1699752A1 (hetero)cyclyl carboxanilides for controlling harmful fungi |
| 09/13/2006 | EP1699748A2 Method for the production of substituted 2-(phenoxymethyl)-benzoic acids |
| 09/13/2006 | EP1613326B1 (3-{3-'(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino]-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 09/13/2006 | EP1097925B1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833003A Sulfonamide anions as catalysts for nco oligomerization |
| 09/13/2006 | CN1832944A Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 09/13/2006 | CN1832932A Biaryl heterocyclic compounds and methods of making and using the same |
| 09/13/2006 | CN1832930A Amide derivative |
| 09/13/2006 | CN1830970A Method for preparing carbamido alanine protected by Na-Boc |
| 09/13/2006 | CN1274688C Synthesis method of 5-hydroxy methyl furazolidone |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105551 Thiazole derivatives for treating PPAR related disorders |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006093354A1 Production intermediate of (s)-2-[3-(n-{[4-(4-fluorophenoxy)phenyl]methyl}carbamoyl)-4-methoxyphenylmethyl]butanoic acid |
| 09/08/2006 | WO2006092074A1 Menthane carboxamide derivatives having cooling properties |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2597415A1 Menthane carboxamide derivatives having cooling properties |
| 09/07/2006 | US20060199967 Process for the purification of substituted benzoxazole compounds |
| 09/07/2006 | US20060199852 Process for the preparation of substituted benzoxazole compounds |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/07/2006 | US20060199772 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 09/07/2006 | US20060199223 Chemiluminescent compounds and their use |
| 09/07/2006 | DE102005009705A1 Use of naphthalene derivatives for the treatment of hyperaldosteronism, heart failure, myocardial fibrosis, hypercortisolism and diabetes mellitus |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698617A1 Method for producing optically active cycloalkylidene bisoxazoline compound and intermediate thereof |
| 09/06/2006 | EP1697355A2 Amidino compounds as cysteine protease inhibitors |
| 09/06/2006 | EP1697316A1 Novel intermediates for the synthesis of (r)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation |
| 09/06/2006 | EP1303308B1 Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | CN1829714A Pna单体和前体 Pna monomers and precursors |
| 09/06/2006 | CN1829697A Aryl-heteroaromatic products, compositions containing same and use thereof |
| 09/06/2006 | CN1829519A Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 09/06/2006 | CN1829513A 5-membered heterocycle-based p-38 inhibitors |
| 09/06/2006 | CN1273456C Thiazole or oxazole derivatives |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102010 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base |
| 09/05/2006 | US7101901 Treating Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 09/05/2006 | US7101880 Peptidic compounds as cysteine protease inhibitors |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 08/31/2006 | WO2006091848A2 Isolated bis-linezolid, preparation thereof, and its use as a reference standard |
| 08/31/2006 | WO2006091777A1 Crystalline forms of linezolid intermediate |
| 08/31/2006 | WO2006091731A2 Processes for the preparation of linezolid intermediate |
| 08/31/2006 | WO2006091669A1 Anti-cancer and anti-microbial oxazolidinones and analogues |
| 08/31/2006 | WO2006090792A1 Novel haloalkylsulfonanilide derivative, herbicide, and method of use thereof |
| 08/31/2006 | WO2006090768A1 Process for production of optically active ppar-activating compound and intermediate of the same |
| 08/31/2006 | WO2006090235A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | WO2006066133A3 Histone deacetylase inhibitors |
| 08/31/2006 | US20060194966 N'-{2-amino-1-(3,5-difluorobenzyl)-3-[(3-; ethylbenzyl)oxy]propyl}-N,N-dipropylisophthalamide; beta-secretase inhibitors; halts or reduces production of A beta peptide from amyloid precursor proteins and reduces or eliminates the formation of beta-amyloid deposits in the brain |
| 08/31/2006 | US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/31/2006 | US20060194825 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194258 Polypeptide array synthesis |
| 08/31/2006 | DE102004038403B4 Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten A process for preparing the enantiomeric forms of cis-configured 3-hydroxycyclohexanecarboxylic acid derivatives |
| 08/31/2006 | CA2602073A1 Processes for the preparation of linezolid intermediate |
| 08/31/2006 | CA2598518A1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 08/31/2006 | CA2597667A1 Anti-cancer and anti-microbial oxazolidinones and analogues |
| 08/31/2006 | CA2588876A1 Crystalline forms of linezolid intermediate |
| 08/30/2006 | EP1695968A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1439885B1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 08/30/2006 | CN1826310A Novel aminobenzophenone compounds |
| 08/29/2006 | US7098228 Indolyl derivatives |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2240735C Process for production of piperidine derivatives |
| 08/29/2006 | CA2149637C Method for the preparation of 1,3-oxazolidin-5-carboxylic acid |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | WO2005108380A3 Process employing controlled crystallization in forming crystals of a pharmaceutical |
| 08/24/2006 | WO2005097114A3 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders |